Ausgabe 2/2018
Inhalt (15 Artikel)
Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?
Joseph M. Obeid, Paul R. Kunk, Victor M. Zaydfudim, Timothy N. Bullock, Craig L. Slingluff Jr., Osama E. Rahma
Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies
Kristina Buder-Bakhaya, Karolina Benesova, Carsten Schulz, Hoda Anwar, Antonia Dimitrakopoulou-Strauss, Tim F. Weber, Alexander Enk, Hanns-Martin Lorenz, Jessica C. Hassel
A filamentous bacteriophage targeted to carcinoembryonic antigen induces tumor regression in mouse models of colorectal cancer
Paola Murgas, Nicolás Bustamante, Nicole Araya, Sebastián Cruz-Gómez, Eduardo Durán, Diana Gaete, César Oyarce, Ernesto López, Andrés Alonso Herrada, Nicolás Ferreira, Hans Pieringer, Alvaro Lladser
Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice
Jill P. Smith, Shangzi Wang, Sandeep Nadella, Sandra A. Jablonski, Louis M. Weiner
Clinicopathologic implications of CD8+/Foxp3+ ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients
Ming-Xiang Zou, Ke-Miao Guo, Guo-Hua Lv, Wei Huang, Jing Li, Xiao-Bin Wang, Yi Jiang, Xiao-Ling She
Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia
Nina Rolf, Kinga K. Smolen, Amina Kariminia, Adam Velenosi, Mario Fidanza, Caron Strahlendorf, Alix E. Seif, Gregor S. D. Reid
NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma
Zhenjiang Liu, Thomas Poiret, Oscar Persson, Qingda Meng, Lalit Rane, Jiri Bartek Jr., Julia Karbach, Hans-Michael Altmannsberger, Christopher Illies, Xiaohua Luo, Inti Harvey-Peredo, Elke Jäger, Ernest Dodoo, Markus Maeurer
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice
Timothy S. Fisher, Andrea T. Hooper, Justin Lucas, Tracey H. Clark, Allison K. Rohner, Bryan Peano, Mark W. Elliott, Konstantinos Tsaparikos, Hui Wang, Jonathan Golas, Maria Gavriil, Nahor Haddish-Berhane, Lioudmila Tchistiakova, Hans-Peter Gerber, Adam R. Root, Chad May
CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer
Yichou Wei, Chao Lin, He Li, Zhiying Xu, Jieti Wang, Ruochen Li, Hao Liu, Heng Zhang, Hongyong He, Jiejie Xu
Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells
Na Li, Jianing Wang, Na Zhang, Mengwei Zhuang, Zhaoyun Zong, Jiahuan Zou, Guosheng Li, Xiaoyan Wang, Huaiyu Zhou, Lining Zhang, Yongyu Shi
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients
Olivier Gasser, Katrina J. Sharples, Catherine Barrow, Geoffrey M. Williams, Evelyn Bauer, Catherine E. Wood, Brigitta Mester, Marina Dzhelali, Graham Caygill, Jeremy Jones, Colin M. Hayman, Victoria A. Hinder, Jerome Macapagal, Monica McCusker, Robert Weinkove, Gavin F. Painter, Margaret A. Brimble, Michael P. Findlay, P. Rod Dunbar, Ian F. Hermans
BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma
Qi Liu, Hongda Zhu, Yun Liu, Sara Musetti, Leaf Huang
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M. Scurti, Kelli A. Hutchens, Constantine Godellas, Ann Lau Clark, Elizabeth Motunrayo Kolawole, Lance M. Hellman, Nishant K. Singh, Fernando A. Huyke, Siao-Yi Wang, Kelly M. Calabrese, Heather D. Embree, Rimas Orentas, Keisuke Shirai, Emilia Dellacecca, Elizabeth Garrett-Mayer, Mingli Li, Jonathan M. Eby, Patrick J. Stiff, Brian D. Evavold, Brian M. Baker, I. Caroline Le Poole, Boro Dropulic, Joseph I. Clark, Michael I. Nishimura
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M. Scurti, Kelli A. Hutchens, Constantine Godellas, Ann Lau Clark, Elizabeth Motunrayo Kolawole, Lance M. Hellman, Nishant K. Singh, Fernando A. Huyke, Siao-Yi Wang, Kelly M. Calabrese, Heather D. Embree, Rimas Orentas, Keisuke Shirai, Emilia Dellacecca, Elizabeth Garrett-Mayer, Mingli Li, Jonathan M. Eby, Patrick J. Stiff, Brian D. Evavold, Brian M. Baker, I. Caroline Le Poole, Boro Dropulic, Joseph I. Clark, Michael I. Nishimura
Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy
Xiaopeng Yuan, Mingjuan Yang, Xiang Chen, Xuhua Zhang, Shrey Sukhadia, Najia Musolino, Huijing Bao, Tingtao Chen, Chen Xu, Qirui Wang, Stephen Santoro, Daniel Ricklin, Jia Hu, Ruihe Lin, Wei Yang, Zhijun Li, Weijun Qin, Aizhi Zhao, Nathalie Scholler, George Coukos